AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|
38.5 C
New York
Thursday, July 2, 2026

Tag: patients

Olympus Announces Full Market Release of AI-Powered Emphysema Screening Program

SeleCT™ Screening Automatically Reviews Existing CT Scans to Help Identify Potential Emphysema Patients CENTER VALLEY, Pa., June 10, 2025 /PRNewswire/ -- Olympus Corp., a global medical...

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.

Staples Canada releases annual Community Impact and Sustainability Report highlighting achievements in environment, equity and education in 2024

Report details progress toward 2025 environmental goals, surpassing three of seven targets ahead of schedule RICHMOND HILL, ON, June 10, 2025 /CNW/ - Staples Canada announces the...

Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment

Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenome™ test can help providers guide obesity treatment by matching patients to GLP-1s...

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO™ Sacroiliac (SI) Joint Fusion System has been successfully used in over 2,500 procedures across the United States. This major milestone underscores the company’s accelerating growth and increasing adoption of its minimally invasive technology by surgeons nationwide.

Claimable Honored in Fast Company’s 2025 World Changing Ideas Awards

Claimable Honored in Fast Company’s 2025 World Changing Ideas Awards. Recognition comes as Claimable expands its impact with support for GLP-1 appeals.

Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer

Target Action (PDUFA) Date set for October 7, 2025 Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and clinically...

Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity™ Test System

Seasoned medtech executive joins as hospital adoption accelerates for breakthrough diagnostic in acute infection and sepsis care SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ -- Inflammatix,...

Rad AI Named to CNBC Disruptor 50 List For Pioneering Generative AI in Healthcare

Recognition comes amid rapid growth, with Rad AI recently securing $68 million in Series C Funding and ranking 19th on the Deloitte Fast 500. SAN...

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and...

Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs
Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs

Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access

The health center will leverage Notable's AI Platform to automate highly manual processes, including registration, intake, and care gap outreach SAN MATEO, Calif., June...

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

Ingelheim, Germany, and San Francisco, Calif., June 10, 2025 | Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, have entered a strategic collaboration agreement. This collaboration brings together Boehringer’s depth in canine cardiology with Eko Health’s powerful AI algorithms and digital stethoscopes – already trusted by healthcare professionals worldwide, with over 650,000 devices sold for use in human medicine. Leveraging their combined expertise, along with Boehringer’s proprietary algorithm developed with support from leading veterinary cardiologists worldwide, the partnership aims to enhance the early detection and diagnosis of heart disease in dogs. A canine-specific detection algorithm will be made available to veterinarians through a purpose-built Eko mobile app launching in 2026.

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients